Pyxis Oncology, Inc. (PYXS)
3.52
-0.37
(-9.51%)
USD |
NASDAQ |
Sep 09, 14:39
Pyxis Oncology 1 Year Total Returns (Daily) : 98.47% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | 98.47% |
| September 04, 2026 | 141.6% |
| September 03, 2026 | 142.5% |
| September 02, 2026 | 182.0% |
| September 01, 2026 | 168.8% |
| August 31, 2026 | 153.1% |
| August 28, 2026 | 142.9% |
| August 27, 2026 | 144.1% |
| August 26, 2026 | 143.8% |
| August 25, 2026 | 120.1% |
| August 24, 2026 | 120.9% |
| August 21, 2026 | 133.3% |
| August 20, 2026 | 169.0% |
| August 19, 2026 | 180.8% |
| August 18, 2026 | 141.1% |
| August 17, 2026 | 145.5% |
| August 14, 2026 | 166.4% |
| August 13, 2026 | 181.3% |
| August 12, 2026 | 205.8% |
| August 11, 2026 | 172.1% |
| August 10, 2026 | 261.3% |
| August 07, 2026 | 248.6% |
| August 06, 2026 | 257.1% |
| August 05, 2026 | 189.8% |
| August 04, 2026 | 187.3% |
| Date | Value |
|---|---|
| August 03, 2026 | 176.4% |
| July 31, 2026 | 136.6% |
| July 30, 2026 | 149.6% |
| July 29, 2026 | 156.1% |
| July 28, 2026 | 137.6% |
| July 27, 2026 | 132.8% |
| July 24, 2026 | 94.78% |
| July 23, 2026 | 127.1% |
| July 22, 2026 | 123.9% |
| July 21, 2026 | 97.35% |
| July 20, 2026 | 99.12% |
| July 17, 2026 | 101.7% |
| July 16, 2026 | 87.40% |
| July 15, 2026 | 109.5% |
| July 14, 2026 | 92.44% |
| July 13, 2026 | 110.3% |
| July 10, 2026 | 124.4% |
| July 09, 2026 | 125.6% |
| July 08, 2026 | 138.1% |
| July 07, 2026 | 169.3% |
| July 06, 2026 | 123.6% |
| July 02, 2026 | 119.2% |
| July 01, 2026 | 163.9% |
| June 30, 2026 | 173.6% |
| June 29, 2026 | 160.0% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 8.63% |
| Alnylam Pharmaceuticals, Inc. | -42.84% |
| Anika Therapeutics, Inc. | 135.3% |
| Savara, Inc. | 43.64% |
| Vericel Corp. | 17.64% |